Pregled bibliografske jedinice broj: 1186756
Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review
Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review // Rheumatology international, 41(4) (2021), 819-825 doi:10.1007/s00296-021-04800-y (međunarodna recenzija, pregledni rad, stručni)
CROSBI ID: 1186756 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Psoas abscess during treatment with intravenous
tocilizumab in a patient with rheumatoid
arthritis: a case-based review
Autori
Vajdić, Ines Doko ; Štimac, Goran ; Pezelj, Ivan ; Mustapić, Matej ; Grazio, Simeon
Izvornik
Rheumatology international (0172-8172) 41(4)
(2021);
819-825
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, stručni
Ključne riječi
Abscess ; Arthritis ; Diagnosis ; Psoas ; Rheumatoid ; Tocilizumab ; Treatment
Sažetak
Interleukin-6 receptor antagonist tocilizumab is a biologic drug used for treating patients with active rheumatoid arthritis (RA) who failed to respond to synthetic or other biologic disease- modifying antirheumatic drugs or where they were contraindicated. Interleukin-6 receptor blockade results in a decrease of disease activity but has some potential adverse effects, the most common being infections. We present a case of a 75-year- old female patient with long-lasting RA, several comorbidities and multiple prior therapies, who developed back pain and general malaise during tocilizumab intravenous treatment. The laboratory findings were typical of toxemia, and the imaging findings revealed large psoas muscle abscess. Surgical and antibiotic treatment was performed with a good outcome. To our knowledge, this has been the first case of a psoas abscess in a patient with RA treated with tocilizumab described in the literature so far. We also present a review of the literature regarding infection, and particularly abscess formation in patients treated with biological disease-modifying antirheumatic drugs, tocilizumab included.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE